Hugh Salter
Company: Anocca
Job title: Chief Scientific Officer
Seminars:
Live Panel Q&A – Ask the Speakers Your Burning Questions 10:40 am
day: Day Two
T-Cell Receptor Targeting of Multiple RAS Mutant Forms in Broad Patient Populations 9:00 am
Characterization of RAS T-cell receptor (TCR) targets TCR discovery and characterization for multiple RAS mutations Challenge and propose of TCR-modified cell therapies targeting RAS mutationsRead more
day: Day Two